A2 Biotherapeutics is advancing its Tmod™ cell engineering platform to create precision CAR T-cell therapies, focusing on restoring health and hope for patients with cancer and other devastating diseases
A2 Biotherapeutics is advancing its Tmod™ cell engineering platform to create precision CAR T-cell therapies, focusing on restoring health and hope for patients with cancer and other devastating diseases.